Robert Murphy Selected Research

Darunavir (Prezista)

8/2015	Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
7/2007	Safety, tolerability, and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced, hepatitis B or C co-infected patients in POWER 1 and 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Murphy Research Topics

Disease

6	Coinfection 01/2022 - 07/2007
4	Liver Diseases (Liver Disease) 01/2019 - 11/2009
4	Inflammation (Inflammations) 07/2017 - 01/2013
3	Hepatitis B 01/2022 - 07/2007
2	Ischemic Stroke 01/2022 - 06/2019
2	Infections 01/2021 - 10/2009
2	Myocardial Infarction 06/2020 - 01/2020
2	Stroke (Strokes) 01/2020 - 06/2019
2	Tuberculosis (Tuberculoses) 04/2018 - 08/2013
2	Neoplasms (Cancer) 01/2018 - 01/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 11/2010
2	Disease Progression 01/2012 - 11/2006
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2012 - 03/2002
2	HIV Infections (HIV Infection) 01/2012 - 04/2009
2	Hypersensitivity (Allergy) 11/2009 - 01/2002
1	COVID-19 01/2022
1	Scoliosis 11/2021
1	Surgical Wound Infection 11/2021
1	Peripheral Nerve Injuries 04/2021
1	Cicatrix (Scar) 04/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Hemorrhagic Stroke 01/2020
1	Dementia (Dementias) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Hemorrhage 01/2020
1	Cognitive Dysfunction 01/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2019
1	Cerebral Hemorrhage 06/2019
1	Carcinogenesis 01/2018
1	Hepatolenticular Degeneration (Wilson's Disease) 07/2017
1	Fatty Liver 07/2017
1	Obesity 07/2017
1	Pain (Aches) 01/2015
1	Virus Diseases (Viral Diseases) 04/2012
1	Brain Neoplasms (Brain Tumor) 01/2012
1	Heart Failure 10/2011
1	Hypertrophy 10/2011
1	Pulmonary Hypertension 10/2011
1	Body Weight (Weight, Body) 10/2011
1	Right Ventricular Hypertrophy 10/2011

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2015
3	Pharmaceutical PreparationsIBA 04/2018 - 01/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2020
2	Ritonavir (Norvir)FDA Link 08/2015 - 07/2007
2	Darunavir (Prezista)FDA Link 08/2015 - 07/2007
2	Integrase InhibitorsIBA 08/2015 - 04/2009
1	Circular DNAIBA 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022
1	isoleucyl-lysyl-valyl-alanyl-valineIBA 04/2021
1	Dendrimers (Dendrons)IBA 04/2021
1	Biocompatible Materials (Biomaterials)IBA 04/2021
1	CollagenIBA 04/2021
1	MetalsIBA 01/2021
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2021
1	CholesterolIBA 01/2021
1	CytokinesIBA 01/2021
1	HydrogelsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 06/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	LeukotrienesIBA 10/2019
1	montelukast (Singulair)FDA Link 10/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2019
1	oxidized low density lipoproteinIBA 06/2019
1	LipidsIBA 06/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2017
1	CopperIBA 07/2017
1	Copper-Transporting ATPasesIBA 07/2017
1	Copper Transport ProteinsIBA 07/2017
1	Raltegravir Potassium FDA Link 08/2015
1	Lipopolysaccharide ReceptorsIBA 08/2015
1	C-Reactive ProteinIBA 08/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 08/2015
1	Antiviral Agents (Antivirals)IBA 08/2015
1	Atazanavir Sulfate (Reyataz)FDA Link 08/2015
1	Interleukin-6 (Interleukin 6)IBA 08/2015
1	fibrin fragment D (D-dimer)IBA 08/2015
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2015
1	Phosphodiesterase InhibitorsIBA 08/2013
1	Sildenafil Citrate (Viagra)FDA Link 08/2013
1	Cilostazol (Pletal)FDA LinkGeneric 08/2013
1	RolipramIBA 08/2013
1	Retinaldehyde (Retinal)IBA 01/2013
1	PlatinumIBA 01/2012
1	Interferon Type IIBA 01/2012
1	Interferon-alpha (Interferon Alfa)IBA 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	satraplatin (JM 216)IBA 01/2012
1	Peptides (Polypeptides)IBA 10/2011
1	Cardiolipins (Cardiolipin)IBA 10/2011

Therapy/Procedure

14	Therapeutics 01/2022 - 03/2002
2	Art Therapy 01/2017 - 08/2015
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Spinal Fusion (Spondylosyndesis) 11/2021
1	Secondary Prevention 06/2019
1	Duration of Therapy 08/2013